Excalibur International Marine (49% Owned By Eft Biotech Holdings)

< BACK TO COMPANY starstarstarstarstar   Business - Company Press Release
1st July 2009, 10:36pm - Views: 746





Business Company EFT BioTech Holdings, Inc. 1 image






MEDIA RELEASE PR35253


Excalibur International Marine (49% Owned by EFT BioTech Holdings)

Completes Inaugural Passenger Crossing of Taiwan Strait


CITY OF INDUSTRY, Calif. and HONG KONG, July 1 /PRNewswire-AsiaNet/ --


     EFT BioTech Holdings, Inc. (Pink Sheets: EFTB), announced today that

Excalibur's Ocean LaLa has successfully completed its inaugural Taiwan

Strait passenger voyage which has been highlighted in multiple news

articles and internet news sites, including the Taiwan Sun, and the Qatar

Tribune.  The article states: 


     "A Taiwan company launched a cruise service with China on Sunday,

making it the first such cross-strait service in 60 years. 


    "With a band playing and dragon dance performing on shore, the 2,292-

tonne Ocean LaLa set sail from the Taichung Harbour for Xiamen, China,

carrying 179 passengers and 23 crew. 


    "The voyage across the Taiwan Strait takes only four-and-a-half-hours,

but it took Taiwan and China 60 years to ease tension and for Taipei to

agree to lift the ban on sea links with the mainland." 


    The Excalibur International Marine Corp, operator of the cruise

service, said that in the initial stage, the Taichung-Xianmen cruise is an

irregular service chartered by travel agencies. 


     "Eventually it will become a regular cruise service going not only to

Xiamen, but also to other Chinese ports like Fuzhou and Shanghai," said Han

Chih-yang, Excalibur's deputy.


     "We are full of confidence for the future of cross-strait tourism, so

we are seeking to buy two larger ships for launching regular cross-strait

service," he said.


    Jack Qin, the President and CEO of EFT BioTech Holdings, stated, "We

are excited to be recognized by the world press and this article shows that

people are truly interested in this much needed passenger and cargo

service."


    About EFT BioTech Holdings, Inc.

    EFT BioTech Holdings, Inc. is a Nevada holding company which conducts

its business through its wholly-owned subsidiary, EFT Biotech Holdings,

Inc., and its wholly owned subsidiaries and various vested interests. EFT

BioTech Holdings, Inc. is an e-commerce company serving consumers with

EFT's "made in USA" neutraceuticals, health and beauty EFT branded products


Although our products are available for sale throughout the world, most

affiliates and consumers are located in China and Hong Kong. The contents

of the Company's website are not incorporated by reference herein.


    Safe Harbor for Forward-Looking Statements

    Statements made in this release with the respect to the Company's

current plans, estimates, strategies and beliefs and other statements that

are not historical are forward-looking statements. Forward-looking

statements include, but are not limited to, those statements using words

Business Company EFT BioTech Holdings, Inc. 2 image

such as "believe," "expect," "plans," "strategy," prospects," "forecast,"

"estimate," "project," "anticipate," "aim," "may" or "might" and words of

similar meaning in connection with a discussion of future operations,

financial performance, events or conditions. From time to time, oral or

written forward-looking statements may also be included in other materials

released to the public. These statements are based on management's

assumptions and belief in light of the information currently available to

it. The company cautions you that a number of important risks and

uncertainties could cause actual results to materially differ from those

discussed in the forward-looking statements, and therefore, you should not

place undue reliance on them. You also should not rely on any obligation of

the Company to update or revise any forward-looking statements, whether as

a result of new information, future events or otherwise. The company

disclaims any such obligation unless required by law. Risks and

uncertainties that might affect the Company include, but are not limited to

(i) the global economic environment in which the Company operates, as well

as the economic conditions in the Company's markets, (ii) levels of

consumer spending, and (iii) exchange rates, particularly between the

Chinese Yen and the U.S. Dollar. Risks and uncertainties also include the

impact of any future events with material adverse impacts.


    For More Information, Please Contact:

    Aero Strategic Advisory, A division of Aero Financial, Inc. 

    Ed Carter

    Telephone: +1-702-982-7732


     SOURCE:  EFT BioTech Holdings, Inc.


    CONTACT:  Ed Carter of Aero Strategic Advisory

              A division of Aero Financial, Inc.

              +1-702-982-7732

    (EFTB)








To view this and other AsiaNet releases please visit http://www.asianetnews.net






news articles logo NEWS ARTICLES
Contact News Articles |Remove this article